STELL 发表于 2025-3-25 05:28:07

http://reply.papertrans.cn/1/74/7397/7397-21.png

Nonporous 发表于 2025-3-25 09:30:13

Submitted on: 12 April 2012.
Revised on: 17 June 2012.
Accepted on: 11 July 2012.

___________________Diabetes Therapy---SPRINGER HEIDELBERG

PAC 发表于 2025-3-25 12:08:15

Submitted on: 23 January 2005.
Revised on: 10 May 2005.
Accepted on: 29 June 2005.

___________________Diabetes Therapy---SPRINGER HEIDELBERG

袋鼠 发表于 2025-3-25 19:51:59

http://reply.papertrans.cn/1/74/7397/7397-24.png

medium 发表于 2025-3-25 20:47:44

http://reply.papertrans.cn/1/74/7397/7397-25.png

类似思想 发表于 2025-3-26 00:27:35

Submitted on: 12 August 2015.
Revised on: 30 November 2015.
Accepted on: 22 December 2015.

___________________Diabetes Therapy---SPRINGER HEIDELBERG

Bricklayer 发表于 2025-3-26 05:02:50

http://reply.papertrans.cn/1/74/7397/7397-27.png

尽管 发表于 2025-3-26 12:01:43

Submitted on: 02 November 2002.
Revised on: 29 January 2003.
Accepted on: 19 March 2003.

___________________Diabetes Therapy---SPRINGER HEIDELBERG

散布 发表于 2025-3-26 14:10:26

http://reply.papertrans.cn/1/74/7397/7397-29.png

Chronological 发表于 2025-3-26 17:25:18

http://reply.papertrans.cn/1/74/7397/7397-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊Diabetes Therapy 2024/2025影响因子:2.801 (DIABETES THER) (1869-6953). (ENDOCRINOLOGY & METABOLISM)(内分泌学和代谢学)Science C